Constitutive and inducible Akt activity promotes resistance to chemotherapy, trastuzumab, or tamoxifen in breast cancer cells

Molecular Cancer Therapeutics

Volumn 1, Issue 9, 2002, Pages 707-717

  Clark, Amy S ^a   West, Kip ^a   Streicher, Samantha ^a   Dennis, Phillip A ^a  

^a NATIONAL CANCER INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

2 MORPHOLINO 8 PHENYLCHROMONE; 2-(4-MORPHOLINYL)-8-PHENYL-4H-1-BENZOPYRAN-4-ONE; AKT1 PROTEIN, HUMAN; ANTINEOPLASTIC AGENT; CHROMONE DERIVATIVE; DOXORUBICIN; ENZYME INHIBITOR; ETOPOSIDE; MONOCLONAL ANTIBODY; MORPHOLINE DERIVATIVE; ONCOPROTEIN; PACLITAXEL; PROTEIN KINASE B; PROTEIN SERINE THREONINE KINASE; TAMOXIFEN; TRASTUZUMAB;

APOPTOSIS; ARTICLE; BREAST TUMOR; CELL CULTURE; DRUG RESISTANCE; ENZYME LINKED IMMUNOSORBENT ASSAY; FLOW CYTOMETRY; GENETIC TRANSFECTION; HUMAN; IMMUNOBLOTTING; METABOLISM; TIME;

ANTIBODIES, MONOCLONAL; ANTINEOPLASTIC AGENTS; ANTINEOPLASTIC AGENTS, PHYTOGENIC; APOPTOSIS; BREAST NEOPLASMS; CHROMONES; DOXORUBICIN; DRUG RESISTANCE, NEOPLASM; ENZYME INHIBITORS; ENZYME-LINKED IMMUNOSORBENT ASSAY; ETOPOSIDE; FLOW CYTOMETRY; HUMANS; IMMUNOBLOTTING; MORPHOLINES; PACLITAXEL; PROTEIN-SERINE-THREONINE KINASES; PROTO-ONCOGENE PROTEINS; PROTO-ONCOGENE PROTEINS C-AKT; TAMOXIFEN; TIME FACTORS; TRANSFECTION; TUMOR CELLS, CULTURED;

EID: 0036633164     PISSN: 15357163     EISSN: 15388514     Source Type: Journal    
DOI: None     Document Type: Article

References (66)

1. Datta, S. R., Brunet, A., and Greenberg, M. E. Cellular survival: a play in three Akts. Genes Dev., 13: 2905-2927, 1999.
2. Bellacosa, A., Testa, J. R., Staal, S. P., and Tsichlis, P. N. A retroviral oncogene, akt, encoding a serine-threonine kinase containing an SH2-like region. Science (Wash. DC), 254: 274-277, 1991. (Pubitemid 21917339)
3. Coffer, P. J., and Woodgett, J. R. Molecular cloning and characterisation of a novel putative protein-serine kinase related to the cAMP-dependent and protein kinase C families [published erratum appears in Eur. J. Biochem., 205: 1217, 1992]. Eur J Biochem., 201: 475-481, 1991.
4. Jones, P. F., Jakubowicz, T., Pitossi, F. J., Maurer, F., and Hemmings, B. A. Molecular cloning and identification of a serine/threonine protein kinase of the second-messenger subfamily. Proc. Natl. Acad. Sci. USA, 88: 4171-4175, 1991. (Pubitemid 21914501)
5. Balendran, A., Casamayor, A., Deak, M., Paterson, A., Gaffney, P., Currie, R., Downes, C. P., and Alessi, D. R. PDK1 acquires PDK2 activity in the presence of a synthetic peptide derived from the carboxyl terminus of PRK2. Curr. Biol., 9: 393-404, 1999. (Pubitemid 29205782)
6. Delcommenne, M., Tan, C., Gray, V., Rue, L., Woodgett, J., and Dedhar, S. Phosphoinositide-3-OH kinase-dependent regulation of glycogen synthase kinase 3 and protein kinase B/AKT by the integrin-linked kinase. Proc. Natl. Acad. Sci. USA, 95: 11211-11216, 1998. (Pubitemid 28450107)
7. Lynch, D. K., Ellis, C. A., Edwards, P. A., and Hiles, I. D. Integrin-linked kinase regulates phosphorylation of serine 473 of protein kinase B by an indirect mechanism. Oncogene, 18: 8024-8032, 1999. (Pubitemid 30050563)
8. Toker, A., and Newton, A. C. Akt/protein kinase B is regulated by autophosphorylation at the hypothetical PDK-2 site. J. Biol. Chem., 275:8271-8274, 2000. (Pubitemid 30180163)
9. Datta, S. R., Dudek, H., Tao, X., Masters, S., Fu, H., Gotoh, Y., and Greenberg, M. E. Akt phosphorylation of BAD couples survival signals to the cell-intrinsic death machinery. Cell, 91: 231-241, 1997. (Pubitemid 27456390)
10. del Peso, L., Gonzalez-Garcia, M., Page, C., Herrera, R., and Nunez, G. Interleukin-3-induced phosphorylation of BAD through the protein kinase Akt. Science (Wash. DC), 278: 687-689, 1997. (Pubitemid 27464966)
11. Cardone, M. H., Roy, N., Stennicke, H. R., Salvesen, G. S., Franke, T. F., Stanbridge, E., Frisch, S., and Reed, J. C. Regulation of cell death protease caspase-9 by phosphorylation [see comments]. Science (Wash. DC), 282: 1318-1321, 1998. (Pubitemid 28524494)
12. Kang, S. S., Kwon, T., Kwon, D. Y., and Do, S. I. Akt protein kinase enhances human telomerase activity through phosphorylation of telomerase reverse transcriptase subunit. J. Biol. Chem., 274: 13085-13090, 1999.
13. Brunet, A., Bonni, A., Zigmond, M. J., Lin, M. Z., Juo, P., Hu, L. S., Anderson, M. J., Arden, K. C., Blenis, J., and Greenberg, M. E. Akt promotes cell survival by phosphorylating and inhibiting a Forkhead transcription factor. Cell, 96: 857-868, 1999. (Pubitemid 29165088)
14. Kops, G. J., de Ruiter, N. D., De Vries-Smits, A. M., Powell, D. R., Bos, J. L., and Burgering, B. M. Direct control of the Forkhead transcription factor AFX by protein kinase B. Nature (Lond.), 398: 630-634, 1999. (Pubitemid 29183692)
15. Ozes, O. N., Mayo, L. D., Gustin, J. A., Pfeffer, S. R., Pfeffer, L. M., and Donner, D. B. NF-κB activation by tumour necrosis factor requires the Akt serine-threonine kinase [see comments]. Nature (Lond.), 401: 82-85, 1999.
16. Romashkova, J. A., and Makarov, S. S. NF-κB is a target of AKT in anti-apoptotic PDGF signalling [see comments]. Nature (Lond.), 401: 86-90, 1999.
17. Dudek, H., Datta, S. R., Franke, T. F., Birnbaum, M. J., Yao, R., Cooper, G. M., Segal, R. A., Kaplan, D. R., and Greenberg, M. E. Regulation of neuronal survival by the serine-threonine protein kinase Akt. Science (Wash. DC), 275: 661-665, 1997. (Pubitemid 27061332)
18. Kauffmann-Zeh, A., Rodriguez-Viciana, P., Ulrich, E., Gilbert, C., Coffer, P., Downward, J., and Evan, G. Suppression of c-Myc-induced apoptosis by Ras signalling through PI(3)K and PKB. Nature (Lond.), 385:544-548, 1997. (Pubitemid 27074674)
19. Kennedy, S. G., Kandel, E. S., Cross, T. K., and Hay, N. Akt/Protein kinase B inhibits cell death by preventing the release of cytochrome c from mitochondria. Mol. Cell. Biol., 19: 5800-5810, 1999. (Pubitemid 29339934)
20. Khwaja, A., Rodriguez-Viciana, P., Wennstrom, S., Warne, P., and Downward, J. Matrix adhesion and ras transformation both activate a phosphoinositide 3-OH kinase and protein kinase B/Akt cellular survival pathway. EMBO J., 16: 2783-2793, 1997. (Pubitemid 27226215)
21. Kulik, G., Klippel, A., and Weber, M. J. Antiapoptotic signalling by the insulin-like growth factor I receptor, phosphatidylinositol 3-kinase, and Akt. Mol. Cell. Biol., 17: 1595-1606, 1997. (Pubitemid 27097389)
22. Chen, R. H., Su, Y. H., Chuang, R. L., and Chang, T. Y. Suppression of transforming growth factor-β-induced apoptosis through a phosphatidylinositol 3-kinase/Akt-dependent pathway. Oncogene, 17: 1959-1968, 1998. (Pubitemid 28488464)
23. Crowder, R. J., and Freeman, R. S. Phosphatidylinositol 3-kinase and Akt protein kinase are necessary and sufficient for the survival of nerve growth factor-dependent sympathetic neurons. J. Neurosci., 18: 2933-2943, 1998. (Pubitemid 28163223)
24. Eves, E. M., Xiong, W., Bellacosa, A., Kennedy, S. G., Tsichlis, P. N., Rosner, M. R., and Hay, N. Akt, a target of phosphatidylinositol 3-kinase, inhibits apoptosis in a differentiating neuronal cell line. Mol. Cell. Biol., 18:2143-2152, 1998. (Pubitemid 28152663)
25. Blair, L. A., Bence-Hanulec, K. K., Mehta, S., Franke, T., Kaplan, D., and Marshall, J. Akt-dependent potentiation of L channels by insulin-like growth factor-1 is required for neuronal survival. J. Neurosci., 19: 1940-1951, 1999. (Pubitemid 29133372)
26. Gerber, H. P., McMurtrey, A., Kowalski, J., Yan, M., Keyt, B. A., Dixit, V., and Ferrara, N. Vascular endothelial growth factor regulates endothelial cell survival through the phosphatidylinositol 3′-kinase/Akt signal transduction pathway. Requirement for Flk-1/KDR activation. J. Biol. Chem., 273: 30336-30343, 1998. (Pubitemid 28545503)
27. Hausler, P., Papoff, G., Eramo, A., Reif, K., Cantrell, D. A., and Ruberti, G. Protection of CD95-mediated apoptosis by activation of phosphatidylinositide 3-kinase and protein kinase B. Eur. J. Immunol., 28: 57-69, 1998. (Pubitemid 28048277)
28. Kulik, G., and Weber, M. J. Akt-dependent and -independent survival signaling pathways utilized by insulin-like growth factor I. Mol. Cell. Biol., 18: 6711-6718, 1998. (Pubitemid 28500558)
29. Rohn, J. L., Hueber, A. O., McCarthy, N. J., Lyon, D., Navarro, P., Burgering, B. M., and Evan, G. I. The opposing roles of the Akt and c-Myc signalling pathways in survival from CD95-mediated apoptosis. Oncogene, 17: 2811-2818, 1998. (Pubitemid 29010051)
30. Chalecka-Franaszek, E., and Chuang, D. M. Lithium activates the serine/threonine kinase Akt-1 and suppresses glutamate-induced inhibition of Akt-1 activity in neurons. Proc. Natl. Acad. Sci. USA, 96: 8745-8750, 1999. (Pubitemid 29354862)
31. Rust, C., Karnitz, L. M., Paya, C. V., Moscat, J., Simari, R. D., and Gores, G. J. The bile acid taurochenodeoxycholate activates a phosphatidylinositol 3-kinase-dependent survival signaling cascade. J. Biol. Chem., 275: 20210-20216, 2000. (Pubitemid 30441633)
32. Brognard, J., Clark, A. S., Ni, Y., and Dennis, P. A. Akt/protein kinase b is constitutively active in non-small cell lung cancer cells and promotes cellular survival and resistance to chemotherapy and radiation. Cancer Res., 61: 3986-3997, 2001. (Pubitemid 32720961)
33. Lali, F. V., Hunt, A. E., Turner, S. J., and Foxwell, B. M. The pyridinyl imidazole inhibitor SB203580 blocks phosphoinositide-dependent protein kinase activity, protein kinase B phosphorylation, and retinoblastoma hyperphosphorylation in interleukin-2-stimulated T cells independently of p38 mitogen-activated protein kinase. J. Biol. Chem., 275: 7395-7402, 2000. (Pubitemid 30146294)
34. Marsh, D. J., Dahia, P. L., Zheng, Z., Liaw, D., Parsons, R., Gorlin, R. J., and Eng, C. Germline mutations in PTEN are present in Bannayan-Zonana syndrome. Nat. Genet., 16: 333-334, 1997.
35. Rhei, E., Kang, L., Bogomolniy, F., Federici, M. G., Borgen, P. I., and Boyd, J. Mutation analysis of the putative tumor suppressor gene PTEN/MMAC1 in primary breast carcinomas. Cancer Res., 57: 3657-3659, 1997. (Pubitemid 27381202)
36. Feilotter, H. E., Coulon, V., McVeigh, J. L., Boag, A. H., Dorion-Bonnet, F., Duboue, B., Latham, W. C., Eng, C., Mulligan, L. M., and Longy, M. Analysis of the 10q23 chromosomal region and the PTEN gene in human sporadic breast carcinoma. Br. J. Cancer, 79: 718-723, 1999. (Pubitemid 29082095)
37. Singh, B., Ittmann, M. M., and Krolewski, J. J. Sporadic breast cancers exhibit loss of heterozygosity on chromosome segment 10q23 close to the Cowden disease locus. Genes Chromosomes Cancer, 21: 166-171, 1998. (Pubitemid 28081244)
38. Li, J., Simpson, L., Takahashi, M., Miliaresis, C., Myers, M. P., Tonks, N., and Parsons, R. The PTEN/MMAC1 tumor suppressor induces cell death that is rescued by the AKT/protein kinase B oncogene. Cancer Res., 58: 5667-5672, 1998. (Pubitemid 29006402)
39. Lu, Y., Lin, Y. Z., LaPushin, R., Cuevas, B., Fang, X., Yu, S. X., Davies, M. A., Khan, H., Furui, T., Mao, M., Zinner, R., Hung, M. C., Steck, P., Siminovitch, K., and Mills, G. B. The PTEN/MMAC1/TEP tumor suppressor gene decreases cell growth and induces apoptosis and anoikis in breast cancer cells. Oncogene, 18: 7034-7045, 1999. (Pubitemid 30028874)
40. Bellacosa, A., de Feo, D., Godwin, A. K., Bell, D. W., Cheng, J. Q., Altomare, D. A., Wan, M., Dubeau, L., Scambia, G., Masciullo, V., et al.Molecular alterations of the AKT2 oncogene in ovarian and breast carcinomas. Int. J. Cancer, 64: 280-285, 1995.
41. Nakatani, K., Thompson, D. A., Barthel, A., Sakaue, H., Liu, W., Weigel, R. J., and Roth, R. A. Up-regulation of Akt3 in estrogen receptor-deficient breast cancers and androgen-independent prostate cancer lines. J. Biol. Chem., 274: 21528-21532, 1999.
42. Hutchinson, J., Jin, J., Cardiff, R. D., Woodgett, J. R., and Muller, W. J. Activation of Akt (protein kinase B) in mammary epithelium provides a critical cell survival signal required for tumor progression. Mol. Cell. Biol., 21: 2203-2212, 2001. (Pubitemid 32479640)
43. Moorehead, R. A., Fata, J. E., Johnson, M. B., and Khokha, R. Inhibition of mammary epithelial apoptosis and sustained phosphorylation of Akt/PKB in MMTV-IGF-II transgenic mice. Cell Death Differ., 8: 16-29, 2001. (Pubitemid 32162217)
44. van Weeren, P. C., de Bruyn, K. M., de Vries-Smits, A. M., van Lint, J., and Burgering, B. M. Essential role for protein kinase B (PKB) in insulin-induced glycogen synthase kinase 3 inactivation. Characterization of dominant-negative mutant of PKB. J. Biol. Chem., 273: 13150-13156, 1998. (Pubitemid 28246883)
45. Kastan, M. B., Zhan, Q., el-Deiry, W. S., Carrier, F., Jacks, T., Walsh, W. V., Plunkett, B. S., Vogelstein, B., and Fornace, A. J., Jr. A mammalian cell cycle checkpoint pathway utilizing p53 and GADD45 is defective in ataxia-telangiectasia. Cell, 71: 587-597, 1992.
46. Webb, J. L. Effects of more than one inhibitor. Enzymes and Metabolic Inhibitors, Vol. 1, pp. 487-512. New York: Academic Press, 1963.
47. Ouyang, Y. B., Zhang, X. H., He, Q. P., Wang, G. X., Siesjo, B. K., and Hu, B. R. Differential phosphorylation at Ser473 and Thr308 of Akt-1 in rat brain following hypoglycemic coma. Brain Res., 876: 191-195, 2000.
48. Kerr, J. F., Wyllie, A. H., and Currie, A. R. Apoptosis: a basic biological phenomenon with wide-ranging implications in tissue kinetics. Br. J. Cancer, 26: 239-257, 1972.
49. Pham, F. H., Sugden, P. H., and Clerk, A. Regulation of protein kinase B and 4E-BP1 by oxidative stress in cardiac myocytes. Circ. Res., 86:1252-1258, 2000. (Pubitemid 30436666)
50. Ushio-Fukai, M., Alexander, R. W., Akers, M., Yin, Q., Fujio, Y., Walsh, K., and Griendling, K. K. Reactive oxygen species mediate the activation of Akt/protein kinase B by angiotensin II in vascular smooth muscle cells. J. Biol. Chem., 274: 22699-22704, 1999.
51. Van der Kaay, J., Beck, M., Gray, A., and Downes, C. P. Distinct phosphatidylinositol 3-kinase lipid products accumulate upon oxidative and osmotic stress and lead to different cellular responses. J. Biol. Chem., 274: 35963-35968, 1999. (Pubitemid 129512906)
52. Wang, X., McCullough, K. D., Franke, T. F., and Holbrook, N. J. Epidermal growth factor receptor-dependent Akt activation by oxidative stress enhances cell survival. J. Biol. Chem., 275: 14624-14631, 2000. (Pubitemid 30339753)
53. Rokudai, S., Fujita, N., Hashimoto, Y., and Tsuruo, T. Cleavage and inactivation of antiapoptotic Akt/PKB by caspases during apoptosis. J. Cell. Physiol., 182: 290-296, 2000. (Pubitemid 30022682)
54. Ng, S. S. W., Tsao, M. S., Chow, S., and Hedley, D. W. Inhibition of phosphatidylinositide 3-kinase enhances gemcitabine-induced apoptosis in human pancreatic cancer cells. Cancer Res., 60: 5451-5455, 2000.
55. Du, W., Liu, A., and Prendergast, G. C. Activation of the PI3′K-AKT pathway masks the proapoptotic effects of farnesyltransferase inhibitors. Cancer Res., 59: 4208-4212, 1999. (Pubitemid 29418727)
56. Nakashio, A., Fujita, N., Rokudai, S., Sato, S., and Tsuruo, T. Prevention of phosphatidylinositol 3′-kinase-Akt survival signaling pathway during topotecan-induced apoptosis. Cancer Res., 60: 5303-5309, 2000.
57. Ibuki, Y., and Goto, R. Suppression of apoptosis by UVB irradiation: survival signaling via PI3- kinase/Akt pathway. Biochem. Biophys. Res. Commun., 279: 872-878, 2000. (Pubitemid 32042869)
58. Nomura, M., Kaji, A., Ma, W. Y., Zhong, S., Liu, G., Bowden, G. T., Miyamoto Ki, K., and Dong, Z. Mitogen- and stress-activated protein kinase-1 mediates activation of Akt by ultraviolet B irradiation. J. Biol. Chem., 11: 25558-25567, 2001.
59. Harari, D., and Yarden, Y. Molecular mechanisms underlying ErbB2/HER2 action in breast cancer. Oncogene, 19: 6102-6114, 2000. (Pubitemid 32059460)
60. Cuello, M., Ettenberg, S. A., Clark, A. S., Keane, M. M., Posner, R. H., Nau, M. M., Dennis, P. A., and Lipkowitz, S. Down-regulation of the erbB-2 receptor by trastuzumab (herceptin) enhances tumor necrosis factor-related apoptosis-inducing ligand-mediated apoptosis in breast and ovarian cancer cell lines that overexpress erbB-2. Cancer Res., 61: 4892-4900, 2001. (Pubitemid 32691907)
61. Simoncini, T., Hafezi-Moghadam, A., Brazil, D. P., Ley, K., Chin, W. W., and Liao, J. K. Interaction of oestrogen receptor with the regulatory subunit of phosphatidylinositol-3-OH kinase. Nature (Lond.), 407: 538-541, 2000.
62. Hisamoto, K., Ohmichi, M., Kurachi, H., Hayakawa, J., Kanda, Y., Nishio, Y., Adachi, K., Tasaka, K., Miyoshi, E., Fujiwara, N., Taniguchi, N., and Murata, Y. Estrogen induces the akt-dependent activation of endothelial nitric oxide synthase in vascular endothelial cells. J. Biol. Chem., 276: 3459-3467, 2001.
63. 2 or heat shock is mediated by phosphoinositide 3-kinase and not by mitogen-activated protein kinase-activated protein kinase-2. Biochem. J., 336: 241-246, 1998.
64. Ma, N., Jin, J., Lu, F., Woodgett, J., and Liu, F. F. The role of protein kinase B (PKB) in modulating heat sensitivity in a human breast cancer cell line. Int. J. Radiat. Oncol. Biol. Phys., 50: 1041-1050, 2001. (Pubitemid 32594843)
65. Beitner-Johnson, D., Rust, R. T., Hsieh, T. C., and Millhorn, D. E. Hypoxia activates Akt and induces phosphorylation of GSK-3 in PC12 cells. Cell Signalling, 13: 23-27, 2001. (Pubitemid 32222969)
66. Alvarez-Tejado, M., Naranjo-Suarez, S., Jimenez, C., Carrera, A. C., Landazuri, M. O., and del Peso, L. Hypoxia induces the activation of the phosphatidylinositol 3-kinase/Akt cell survival pathway in PC12 cells: protective role in apoptosis. J. Biol. Chem., 9: 22368-22374, 2001.